Terms: = Kidney tumors AND PBRM1, BAF180, 55193, PB1, MGC156156, MGC156155 AND Diagnosis
12 results:
1. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
Sahu DK; Singh N; Das M; Rawat J; Gupta DK
Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
[TBL] [Abstract] [Full Text] [Related]
2. Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma.
He X; Tian F; Guo F; Zhang F; Zhang H; Ji J; Zhao L; He J; Xiao Y; Li L; Wei C; Huang C; Li Y; Zhang F; Yang B; Ye H; Wang F
BMC Med; 2022 Aug; 20(1):270. PubMed ID: 36002886
[TBL] [Abstract] [Full Text] [Related]
3. Undifferentiated and dedifferentiated urological carcinomas: lessons learned from the recent developments.
Agaimy A; Hartmann A; Trpkov K; Hes O
Semin Diagn Pathol; 2021 Nov; 38(6):152-162. PubMed ID: 34579992
[TBL] [Abstract] [Full Text] [Related]
4. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K; Hes O; Williamson SR; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Gill AJ
Mod Pathol; 2021 Jul; 34(7):1392-1424. PubMed ID: 33664427
[TBL] [Abstract] [Full Text] [Related]
5. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
Linehan WM; Ricketts CJ
Nat Rev Urol; 2019 Sep; 16(9):539-552. PubMed ID: 31278395
[TBL] [Abstract] [Full Text] [Related]
6. [Pathological and molecular features of malignancies underlined by BAF complexes inactivation].
Le Quang M; Ranchère-Vince D; Le Loarer F
Ann Pathol; 2019 Dec; 39(6):399-413. PubMed ID: 31255411
[TBL] [Abstract] [Full Text] [Related]
7. Design of a Targeted Sequencing Assay to Detect Rare Mutations in Circulating Tumor DNA.
Chen J; Chen J; He F; Huang Y; Lu S; Fan H; Wang M; Xu R
Genet Test Mol Biomarkers; 2019 Apr; 23(4):264-269. PubMed ID: 30986100
[TBL] [Abstract] [Full Text] [Related]
8. Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations.
Manley BJ; Reznik E; Ghanaat M; Kashan M; Becerra MF; Casuscelli J; Tennenbaum D; Redzematovic A; Carlo MI; Sato Y; Arcila M; Voss MH; Feldman DR; Motzer RJ; Russo P; Coleman J; Hsieh JJ; Hakimi AA
Urol Oncol; 2019 Jan; 37(1):12-17. PubMed ID: 29132830
[TBL] [Abstract] [Full Text] [Related]
9. Genetic characterization of Polish ccRCC patients: somatic mutation analysis of pbrm1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA.
Kluzek K; Srebniak MI; Majer W; Ida A; Milecki T; Huminska K; van der Helm RM; Silesian A; Wrzesinski TM; Wojciechowicz J; Beverloo BH; Kwias Z; Bluyssen HAR; Wesoly J
Oncotarget; 2017 Apr; 8(17):28558-28574. PubMed ID: 28212566
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive Genomic Profiling of Renal Cell Carcinoma at Initial diagnosis and Putative Local Recurrence.
Chalmers ZR; Johnson A; Ali SM; Frampton GM; Miller V; Ross JS; Pal SK
Eur Urol Focus; 2018 Mar; 4(2):267-269. PubMed ID: 28753749
[TBL] [Abstract] [Full Text] [Related]
11. Metastatic renal cell carcinoma without evidence of a renal primary.
Costantino C; Thomas GV; Ryan C; Coakley FV; Troxell ML
Int Urol Nephrol; 2016 Jan; 48(1):73-7. PubMed ID: 26527083
[TBL] [Abstract] [Full Text] [Related]
12. Frontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinoma.
Czarnecka AM; Kornakiewicz A; Kukwa W; Szczylik C
Future Oncol; 2014 May; 10(6):1095-111. PubMed ID: 24941992
[TBL] [Abstract] [Full Text] [Related]
